Early Initiation of Statins After Diagnosis of Type 2 Diabetes Associated with a Lower Risk of Dementia
Researchers found statin use after a type 2 diabetes diagnosis was linked to a 10% lower dementia risk, rising to 15% when started early.
7 Articles
7 Articles
A recent scientific study has shown that the early initiation of cholesterol reduction drugs is associated with the low risk of dementia in infected persons.
Early initiation of statins after diagnosis of type 2 diabetes associated with a lower risk of dementia
Early initiation of statins after diagnosis of type 2 diabetes was associated with a lower risk of dementia, according to a study presented at ESC Congress 2026 and published in The Lancet Regional Health – Europe.
A 15-year study found that type 2 diabetes patients who used statins had a lower risk of developing dementia. The findings suggest that starting cholesterol treatment, especially at an earlier age, may also be advantageous for brain health.
The early initiation of statins following the diagnosis of type 2 diabetes was associated with a lower risk of dementia, according to a study presented at Congress ESC 2026 and published in 'The Lancet Regional Health – Europe'. The entry Statins are associated with a lower risk of dementia in patients with type 2 diabetes was first published in Salud a Diario.
Cardiology Saradomingo Congress ESC 2026 Dementia is a disease whose frequency is increasing as the population ages and, as it does not yet have effective curative treatments, prevention is a priority. Almost half of cases of dementia could theoretically be prevented by eliminating a number of risk factors, including high levels of LDL cholesterol from the middle age, something common in people with type 2 diabetes, who also have a higher risk o…
Coverage Details
Bias Distribution
- 67% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
